Cargando…
Risk factors for surgical site infection and association of surgical site infection with survival of lower rectal cancer patients without clinical lateral pelvic lymph node metastasis (clinical Stage II/III): Analysis of data from JCOG0212
This study aimed to examine the risk factors for surgical site infection (SSI) and the association of that with recurrence in JCOG0212. The results for secondary endpoints showed that compared with the mesorectal excision (ME) alone group, ME with lateral lymph node dissection (LLND) group showed si...
Autores principales: | Katsumata, Kenji, Enomoto, Masanobu, Ishizaki, Tetsuo, Fujita, Shin, Kanemitsu, Yukihide, Ito, Masaaki, Shiomi, Akio, Komori, Koji, Ohue, Masayuki, Ota, Mitsuyoshi, Akazai, Yoshihiro, Shiozawa, Manabu, Yamaguchi, Takashi, Bando, Hiroyuki, Sekimoto, Mitugu, Kobatake, Takaya, Machida, Ryunosuke, Akasu, Takayuki, Moriya, Yoshihiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8510931/ https://www.ncbi.nlm.nih.gov/pubmed/34406563 http://dx.doi.org/10.1007/s10585-021-10117-8 |
Ejemplares similares
-
Preoperative and postoperative prognostic factors of patients with stage II/III lower rectal cancer without neoadjuvant therapy in the clinical trial (JCOG0212)
por: Ohue, Masayuki, et al.
Publicado: (2021) -
Genomic landscape and its prognostic significance in stage III colorectal cancer: JCOG1506A1, an ancillary of JCOG0910
por: Shida, Dai, et al.
Publicado: (2023) -
A randomized controlled trial comparing perioperative vs. postoperative mFOLFOX6 for lower rectal cancer with suspected lateral pelvic lymph node metastasis (JCOG1310): a phase II/III randomized controlled trial
por: Ohue, Masayuki, et al.
Publicado: (2022) -
A Phase II/III randomized controlled trial comparing perioperative versus postoperative chemotherapy with mFOLFOX6 for lower rectal cancer with suspected lateral pelvic node metastasis: Japan Clinical Oncology Group Study JCOG1310 (PRECIOUS study)
por: Ohue, Masayuki, et al.
Publicado: (2017) -
Postoperative Chemoradiotherapy After Local Resection for High-Risk T1 to T2 Low Rectal Cancer: Results of a Single-Arm, Multi-Institutional, Phase II Clinical Trial
por: Sasaki, Takeshi, et al.
Publicado: (2017)